Clinical trial

Fentanyl Matrix in Lung Cancer Pain

NCT01060137

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-05-01

PhasePHASE4

Study timeline

Study start (unknown)2006-05-01Date precision: month

Registry last updated2010-02-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerverified · MONDO: lung cancer

Painunresolved

Interventions

fentanyl matrixDRUG

Sponsors & collaborators

Janssen Korea, Ltd., Korealead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01060137 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.